Dmtherapeutics
DM Therapeutics develops gene therapies utilizing their proprietary Dark Matter DNA platform to create safer and more precise treatments. This platform is designed to address challenging genetic diseases with the aim of providing curative options. The company focuses on translating advanced science into accessible genetic cures for patients.
Traction –/10
HQ unknown
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- DM Therapeutics develops gene therapies utilizing their proprietary Dark Matter DNA platform to create safer and more precise treatments. This platform is designed to address challenging genetic diseases with the aim of providing curative options. The company focuses on translating advanced science into accessible genetic cures for patients.